<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
------------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
---------------------
Date of Report (Date of earliest
event reported)
January 12, 2001 (January 10, 2001)
AFFYMETRIX, INC
------------------------------------------------------
(Exact name of registrant as specified in its charter)
DELAWARE 0-28218 77-0319159
-------------- ------------------------ -------------------
(State of (Commission File Number) (IRS Employer
incorporation) Identification No.)
3380 Central Expressway, Santa Clara, California 95051
--------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
(408) 731-5000
-------------------------------
(Registrant's telephone number,
including area code)
N/A
-------------------------------------------------------------
(Former name or former address, if changed since last report)
-1-
<PAGE>
Items 1-4.
Not Applicable.
Item 5. OTHER EVENTS.
On January 10, 2001, the Board of Patent Appeals and Interferences of the
United States Patent and Trademark Office issued to Affymetrix, Inc. (the
"Company") a Notice Declaring Interference and has ordered the commencement of
an interference proceeding between the Company and Oxford Gene Technology
Limited ("OGT") involving certain claims of a Patent Application relating to
nucleic acid arrays owned by the Company, and certain claims of OGT's United
States Patent 6,054,270 relating to nucleic acid arrays.
Items 6-9.
Not Applicable.
-2-
<PAGE>
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
AFFYMETRIX, INC.
By: /s/ VERN NORVIEL
-------------------------
Name: Vern Norviel
Title: Senior Vice President
and General Counsel
Date: January 12, 2001
-3-
